2007
DOI: 10.1271/bbb.60684
|View full text |Cite
|
Sign up to set email alerts
|

High Rabdosiin and Rosmarinic Acid Production inEritrichium sericeumCallus Cultures and the Effect of the Calli on Masugi-Nephritis in Rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
18
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 22 publications
(18 citation statements)
references
References 25 publications
(45 reference statements)
0
18
0
Order By: Relevance
“…To change the rabdosiin/RA ratio to increase rabdosiin accumulation, elicitation of E. sericeum calli (E-4 line) by cuprum ions was performed (Inyushkina et al, 2007). The total content of polyphenols in the Cu +2 -glycerateelicited calli was similar to that in the non-elicited calli, but the rabdosiin proportion increased substantially, up to 4.1% of dry weight.…”
Section: Improvement Of Production Characteristicsmentioning
confidence: 98%
See 4 more Smart Citations
“…To change the rabdosiin/RA ratio to increase rabdosiin accumulation, elicitation of E. sericeum calli (E-4 line) by cuprum ions was performed (Inyushkina et al, 2007). The total content of polyphenols in the Cu +2 -glycerateelicited calli was similar to that in the non-elicited calli, but the rabdosiin proportion increased substantially, up to 4.1% of dry weight.…”
Section: Improvement Of Production Characteristicsmentioning
confidence: 98%
“…Skin protection against atopic dermatitis Jang et al, 2011 Protection of neurons against insults a Rosmarinic acid is a promising neuroprotective compound of potential use at the nutritional/ pharmaceutical interface Treatment of retinopathy Kim et al, 2009 Inhibition of TNF-α-induced ROS generation and NF-κB activation and activation of TNF-α-induced apoptosis a Ito et al, 1998 Hydroxyl radical scavenging (activity: rabdosiin > RA = Therapeutic agent for treatment of allergy ascorbic acid > caffeic acid) a Dose-dependent inhibition of excessive hyaluronidase activity (rabdosiin > RA > caffeic acid) a Inhibition of hexosaminidase release from RBL-2H3 cells (rabdosiin = caffeic acid > RA) a Anti-HIV activity a Inhibition of human immunodeficiency virus Kashiwada et al, 1995 Inhibition of HIV-1 integrase and DNA topoisomerase (activity: rabdosiin > RA) a Tewtrakul et al, 2003;Abd-Elazem et al, 2002 Anti-glomerulonephritic activity in rats with induced Masugi-nephritis (in combination with RA) b Treatment of acute forms of renal pathology Inyushkina et al, 2007;Bryukhanov et al, 2008 Lithospermic acid B (salvianolic acid B) Alleviation of symptoms connected with renal pathology a,b,c Treatment of diabetic nephropathy and microalbuminuria Li et al, 2001;Kang et al, 2008;Luo et al, 2008;Yao et al, 2009 Cardioprotective effect and improvement of myocardial microcirculation b Promising for treatment of diseases connected with microcirculatory injuries He et al, 2008 Protection of cerebral microvascular endothelial cells against H 2 O 2 -induced apoptosis a Liu et al, 2007 Anti-atherosclerotic effect b Hur et al, 2008 Protection of human endothelial cells from oxidative stress-induced damage a Wu et al, 2009 Anticancer activity associated with the prevention and treatment of head and neck squamous-cell carcinoma a,b (Paluszczak et al, 2010). RA was found to inhibit the migration of MDA-MB-231BO human bone-homing breast cancer cells and inhibited bone metastasis from breast carcinomas, mainly via the receptor activator of NF-κB ligand (RANKL)/RANK/osteoprotegerin pathway, and by simultaneously suppressing the expression of interleukin-8 .…”
Section: Rosmarinic Acidmentioning
confidence: 99%
See 3 more Smart Citations